Low dose Idarubicine, Vincristin, Prednisone, and G-CSF plus ATRA for the treatment of poor risk myelodysplastic syndrome (MDS)


Unal A., Cetin M. , Eser B.

EUROPEAN JOURNAL OF CANCER, cilt.35, 1999 (SCI İndekslerine Giren Dergi) identifier